ARMISTICE CAPITAL, LLC

Position in GRFS — Grifols SA

CIK 1601086 NEW YORK, NY

Position in GRFS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,786,880

-$3,176,880 QoQ

Shares Held

2,936,000

-1.7% QoQ

Ownership

0.431%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

of 164 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $110,331,379 across 6 Drug Manufacturers - General names. GRFS ranks #2 (18.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	1,064,000	$45,390,240
2	GRFS	Grifols SA This page	2,936,000	$20,786,880
3	GSK	GSK plc	300,000	$15,726,000
4	NVO	Novo Nordisk A S	312,000	$14,957,280
5	BMY	Bristol Myers Squibb Co	233,790	$13,470,979
6	MDCX	Medicus Pharma Ltd.	60,600	$0

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,786,880	2,936,000	-1.7%	Shares	Sole	2026-08-14
2026-03-31	$23,963,760	2,988,000	+7.9%	Shares	Sole	2026-05-15
2025-12-31	$25,880,800	2,768,000	+23.8%	Shares	Sole	2026-02-17
2025-09-30	$22,270,560	2,236,000	-69.4%	Shares	Sole	2025-11-17
2025-06-30	$65,973,920	7,298,000	-21.3%	Shares	Sole	2025-08-14
2025-03-31	$65,966,580	9,278,000	-7.6%	Shares	Sole	2025-05-15
2024-12-31	$74,667,840	10,036,000	+5.2%	Shares	Sole	2025-02-14
2024-09-30	$84,679,680	9,536,000	+20.8%	Shares	Sole	2024-11-14
2024-06-30	$49,798,520	7,892,000	+18.7%	Shares	Sole	2024-08-14
2024-03-31	$44,408,640	6,648,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.